Amylyx Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
49.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.93
|
0.00
|
0.93
|
100.00%
|
|
2022-12-31
|
-0.84
|
0.00
|
0.84
|
100.00%
|
|
2022-09-30
|
-0.97
|
-0.92
|
0.05
|
5.15%
|
|
2022-06-30
|
-0.87
|
-0.93
|
-0.06
|
-6.90%
|
|
2022-03-31
|
-0.69
|
-0.93
|
-0.24
|
-34.78%
|
|
2021-12-31
|
-0.64
|
-4.15
|
-3.51
|
-548.44%
|
|
2021-09-30
|
0.00
|
-3.81
|
-3.81
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.78
|
|
2021-12-31
|
-7.96
|